If you or your loved one has been diagnosed with advanced CSCC, you may be feeling overwhelmed. But you are not alone. Your doctor can help you find the right treatment option.
UNLOXCYT is a type of immunotherapy that helps your immune system find and attack cancer cells. Learn more by reading through the information below. Talk to your doctor to see if UNLOXCYT may be right for you.
UNLOXCYT was proven to work in patients with metastatic and locally advanced CSCC. In some patients, the cancer shrank, and in others, it could no longer be seen.
Most patients who responded to treatment continued to respond for 12 months or more.
As with any treatment, some patients who took UNLOXCYT experienced side effects, but they were usually mild to moderate. See a list of the most common side effects here.
Every day, your immune system protects you from various health threats, including cancer. Some immune cells, like T cells, specialize in recognizing and attacking cancer cells. But cancer often finds ways to hide. One of the tricks it uses is making a protein called PD-L1, which attaches to immune cell proteins called PD-1 and B7.1. This sends a “stop” signal to the T cells, so they stop attacking the cancer, allowing it to grow.
UNLOXCYT is a type of medicine called an immunotherapy. It works by binding to PD-L1—the protein that helps cancer cells hide—and releasing the brakes on your immune system. This means your T cells can find and attack cancer cells again. UNLOXCYT may also help the immune system more directly by helping other immune cells, called natural killer cells, recognize and kill the cancer cells.
UNLOXCYT also allows another protein called PD-L2 to keep working. This helps prevent your immune system from going too far when it is activated, which can sometimes be a reason why you may experience certain types of immune-related side effects.
You’ll receive UNLOXCYT at an infusion center or clinic under the care of a healthcare professional.
You’ll get treatment every 3 weeks. Your doctor will also check your progress and watch for side effects at these appointments.
A typical infusion takes about 60 minutes. Your doctor may also provide medicine beforehand to help manage side effects.
Have ever had an organ or stem cell transplant
Have an autoimmune condition
Have had surgery or radiation treatment in the past few months
Take any medicines, vitamins, or supplements
Are pregnant, planning to become pregnant, breastfeeding or plan to breastfeed*
Monitor you for any side effects during and after the infusion
Adjust the infusion rate if needed (for example, by slowing down, pausing, or stopping the infusion)
Provide additional medications as needed to help manage side effects
Do blood tests to check for liver, kidney, or thyroid side effects
Sign up to receive information about UNLOXCYT and access resources to help you feel confident and supported throughout you or your loved one's treatment.
*Required fields
UNLOXCYT (cosibelimab-ipdl) is a prescription medicine used to treat adults with a type of skin cancer called cutaneous squamous cell carcinoma (CSCC). UNLOXCYT may be used to treat CSCC that has spread or cannot be cured by surgery or radiation.
It is not known if UNLOXCYT is safe and effective in children.
UNLOXCYT works with your immune system. It can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. You can have more than one of these problems at the same time. These problems may happen anytime during treatment or even after your treatment has ended.
Call or see your healthcare provider right away if you develop any new or worsening signs or symptoms including: lung problems, intestinal, liver, hormone gland, kidney and skin problems.
Problems can also happen in other organs and tissues. Call or see your healthcare provider right away if you have any new or worsening signs or symptoms which may include chest pain, irregular heartbeat, shortness of breath, sleepiness, memory problems, changes in mood or behavior, stiff neck, balance problems, tingling or numbness of the arms or legs, eye problems, or bruising.
Infusion reactions can sometimes be severe or life-threatening. Signs and symptoms of infusion reactions may include nausea, dizziness, chills or shaking, feeling like passing out, itching or rash, fever, flushing, back or neck pain, shortness of breath or wheezing.
Rejection of a transplanted organ. Your healthcare provider should tell you what signs and symptoms you should report and monitor you, depending on the type of organ transplant that you have had. There may be complications, including graft-versus-host disease (GVHD), in people who have received a bone marrow (stem cell) transplant that uses donor stem cells. These complications can be serious and can lead to death. These complications may happen if you underwent transplantation either before or after being treated with UNLOXCYT. Your healthcare provider will monitor you for these complications.
Getting medical treatment right away may help keep these problems from becoming more serious. Your healthcare provider will check you for these problems during your treatment with UNLOXCYT. Your healthcare provider may treat you with corticosteroid or hormone replacement medicines. Your healthcare provider may also need to delay or completely stop treatment with UNLOXCYT if you have severe side effects.
The most common side effects of UNLOXCYT include tiredness or weakness, muscle or bone pain, rash, diarrhea, low thyroid hormone levels (hypothyroidism), constipation, nausea, headache, itchy skin, swelling, infection, and urinary tract infection. These are not all the possible side effects of UNLOXCYT.
UNLOXCYT can cause fetal harm. Females of reproductive potential should use effective contraception. Breastfeeding should be avoided. Discuss with your healthcare provider.
Your healthcare provider will give you UNLOXCYT into your vein through an intravenous (IV) line over 60 minutes, usually every three weeks. Your healthcare provider will decide how many treatments you will need and will do blood tests to check you for side effects.
Your healthcare provider may treat you with corticosteroid or hormone replacement medicines. Your healthcare provider may also need to delay or completely stop treatment with UNLOXCYT if you have severe side effects.
You are encouraged to report side effects of UNLOXCYT to FDA: visit www.fda.gov/medwatch; or call 1-800-FDA-1088. You are also encouraged to report SUSPECTED ADVERSE REACTIONS or any side effects or ADEs (adverse drug events) to our Drug Safety Department at 1-800-406-7984 or DrugSafety.USoperations@sunpharma.com (preferred) with as much information as available.
UNLOXCYT (cosibelimab-ipdl) is a prescription medicine used to treat adults with a type of skin cancer called cutaneous squamous cell carcinoma (CSCC). UNLOXCYT may be used to treat CSCC that has spread or cannot be cured by surgery or radiation.
It is not known if UNLOXCYT is safe and effective in children.
UNLOXCYT works with your immune system. It can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. You can have more than one of these problems at the same time. These problems may happen anytime during treatment or even after your treatment has ended.
Call or see your healthcare provider right away if you develop any new or worsening signs or symptoms including: lung problems, intestinal, liver, hormone gland, kidney and skin problems.
Problems can also happen in other organs and tissues. Call or see your healthcare provider right away if you have any new or worsening signs or symptoms which may include chest pain, irregular heartbeat, shortness of breath, sleepiness, memory problems, changes in mood or behavior, stiff neck, balance problems, tingling or numbness of the arms or legs, eye problems, or bruising.
Infusion reactions can sometimes be severe or life-threatening. Signs and symptoms of infusion reactions may include nausea, dizziness, chills or shaking, feeling like passing out, itching or rash, fever, flushing, back or neck pain, shortness of breath or wheezing.
Rejection of a transplanted organ. Your healthcare provider should tell you what signs and symptoms you should report and monitor you, depending on the type of organ transplant that you have had. There may be complications, including graft-versus-host disease (GVHD), in people who have received a bone marrow (stem cell) transplant that uses donor stem cells. These complications can be serious and can lead to death. These complications may happen if you underwent transplantation either before or after being treated with UNLOXCYT. Your healthcare provider will monitor you for these complications.
Getting medical treatment right away may help keep these problems from becoming more serious. Your healthcare provider will check you for these problems during your treatment with UNLOXCYT. Your healthcare provider may treat you with corticosteroid or hormone replacement medicines. Your healthcare provider may also need to delay or completely stop treatment with UNLOXCYT if you have severe side effects.
The most common side effects of UNLOXCYT include tiredness or weakness, muscle or bone pain, rash, diarrhea, low thyroid hormone levels (hypothyroidism), constipation, nausea, headache, itchy skin, swelling, infection, and urinary tract infection. These are not all the possible side effects of UNLOXCYT.
UNLOXCYT can cause fetal harm. Females of reproductive potential should use effective contraception. Breastfeeding should be avoided. Discuss with your healthcare provider.
Your healthcare provider will give you UNLOXCYT into your vein through an intravenous (IV) line over 60 minutes, usually every three weeks. Your healthcare provider will decide how many treatments you will need and will do blood tests to check you for side effects.
Your healthcare provider may treat you with corticosteroid or hormone replacement medicines. Your healthcare provider may also need to delay or completely stop treatment with UNLOXCYT if you have severe side effects.
You are encouraged to report side effects of UNLOXCYT to FDA: visit www.fda.gov/medwatch; or call 1-800-FDA-1088. You are also encouraged to report SUSPECTED ADVERSE REACTIONS or any side effects or ADEs (adverse drug events) to our Drug Safety Department at 1-800-406-7984 or DrugSafety.USoperations@sunpharma.com (preferred) with as much information as available.